Nobutaka Tani
- Nephrology top 10%
-
- Immune Response and Inflammation 2
-
- Lipoproteins and Cardiovascular Health 5
- Tissue Engineering and Regenerative Medicine 2
-
- Antiplatelet Therapy and Cardiovascular Diseases 5
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 3
-
- Advanced Glycation End Products research 3
-
- Sepsis Diagnosis and Treatment 2
- Co-authors
- Satoshi TakadaK. HatanakaAkira YamamotoShinji YokoyamaRikuro HAYASHIHidetoshi KutsukiTakehisa MatsudaTohru Funahashi
- Cited by
- NephrologyHematologyRheumatology
- Journals
- Critical Care Medicine (1 paper)Annals of the Rheumatic Diseases (1 paper)Atherosclerosis (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Nobutaka Tani
22 papers receiving 439 citations
Peers
Comparison fields: 5 of 81
- Nephrology 66
- Hematology 65
- Rheumatology 79
- Immunology 91
- Surgery 186
Countries citing papers authored by Nobutaka Tani
This map shows the geographic impact of Nobutaka Tani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobutaka Tani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobutaka Tani more than expected).
Fields of papers citing papers by Nobutaka Tani
This network shows the impact of papers produced by Nobutaka Tani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobutaka Tani. The network helps show where Nobutaka Tani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nobutaka Tani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 3 | |
| 2 | 2006 | 33 | |
| 3 | 2002 | 12 | |
| 4 | 2002 | 26 | |
| 5 | 1999 | 1 | |
| 6 | 1998 | 39 | |
| 7 | 1998 | 22 | |
| 8 | 1996 | 23 | |
| 9 | Development of Beta-2-Microglobulin Adsorbent for Direct Hemoperfusion(New Adsorbent,General Presentation,Proceedings of the Thirteenth Annual Meeting of Japanese Society for Apheresis) | 1994 | 0 |
| 10 | 1993 | 36 | |
| 11 | 1993 | 21 | |
| 12 | 1993 | 16 | |
| 13 | 1993 | 37 | |
| 14 | 1992 | 6 | |
| 15 | 1992 | 6 | |
| 16 | 1990 | 10 | |
| 17 | 1990 | 20 | |
| 18 | 1989 | 21 | |
| 19 | 1986 | 16 | |
| 20 | 1984 | 91 |
About Nobutaka Tani
Nobutaka Tani is a scholar working on Clinical Biochemistry, Critical Care and Intensive Care Medicine and Rheumatology, having authored 23 papers that have together received 461 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Lipoproteins and Cardiovascular Health (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Advanced Glycation End Products research (3 papers), Tissue Engineering and Regenerative Medicine (2 papers), Immune Response and Inflammation (2 papers) and Sepsis Diagnosis and Treatment (2 papers). The work is most often cited by research in Nephrology (66 citations), Hematology (65 citations) and Rheumatology (79 citations). Nobutaka Tani has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Satoshi Takada, K. Hatanaka, Akira Yamamoto, Shinji Yokoyama, Rikuro HAYASHI, Hidetoshi Kutsuki, Takehisa Matsuda, Tohru Funahashi, S Aotsuka and Kensuke Kondo. Their work appears in journals such as Critical Care Medicine, Annals of the Rheumatic Diseases and Atherosclerosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.